Ralliant Corporation $RAL Shares Sold by APG Asset Management N.V.

APG Asset Management N.V. lowered its holdings in Ralliant Corporation (NYSE:RAL) by 75.6% in the third quarter, Holdings Channel.com reports. The firm owned 19,803 shares of the company’s stock after selling 61,433 shares during the period. APG Asset Management N.V.’s holdings in Ralliant were worth $866,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in RAL. JPMorgan Chase & Co. purchased a new stake in Ralliant in the second quarter valued at approximately $18,494,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in Ralliant during the second quarter worth approximately $1,410,000. Vanguard Group Inc. boosted its holdings in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock valued at $637,995,000 after purchasing an additional 1,415,327 shares during the last quarter. Welch & Forbes LLC purchased a new stake in shares of Ralliant during the 3rd quarter valued at $854,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Ralliant by 5,269.9% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 317,038 shares of the company’s stock worth $14,000,000 after buying an additional 311,134 shares during the last quarter.

Insiders Place Their Bets

In other Ralliant news, SVP Amir A. Kazmi bought 2,545 shares of the business’s stock in a transaction on Friday, February 6th. The shares were bought at an average cost of $39.27 per share, with a total value of $99,942.15. Following the transaction, the senior vice president directly owned 39,699 shares in the company, valued at approximately $1,558,979.73. This trade represents a 6.85% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Kevin E. Bryant bought 1,250 shares of Ralliant stock in a transaction dated Friday, February 6th. The shares were acquired at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the purchase, the director owned 4,653 shares in the company, valued at approximately $185,980.41. The trade was a 36.73% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders bought 8,145 shares of company stock worth $332,233.

Ralliant Trading Down 2.0%

NYSE RAL opened at $45.81 on Wednesday. The stock has a market cap of $5.12 billion and a P/E ratio of 23.37. The company’s fifty day simple moving average is $49.28 and its 200-day simple moving average is $46.63. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The firm’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be paid a $0.05 dividend. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant’s payout ratio is 10.20%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Morgan Stanley restated an “overweight” rating and set a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Truist Financial dropped their target price on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a research report on Friday, February 6th. Citigroup cut their price target on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Finally, Oppenheimer dropped their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $50.50.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.